New Genes in the Carcinogenesis of Colorectal Cancer
NCT03261752 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 62
Last updated 2018-07-26
Summary
Colo rectal cancer is one of the greatest ,mutual malignancies worldwide ,accounting for an estimated 1.3 million new cases and \>500,000 mortality ⁄ year . is the fourth leading cause of cancer-associated mortality worldwide with speedily ,cumulative ,occurrence rate in the worldwide
Conditions
- Colo-rectal Cancer
Interventions
- DIAGNOSTIC_TEST
-
blood sample
Total genomic DNA will be extracted DNA extraction kit using a QIAamp DNA Blood Mini kit .Genetic analysis of both SPG20 \&STK31 by RTPCR.
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 35 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-10-01
- Primary Completion
- 2019-09-01
- Completion
- 2019-09-30
More Related Trials
-
Genetic and Epigenetic Determinants of Response to Fluorouracil-based Adjuvant Chemotherapy in Patients With Stage III Colorectal Cancer
NCT03127111 ·Status: NOT_YET_RECRUITING
-
Oral & Faecal Microbiota Analysis in Patients With Rectal Cancer Requiring Pre-operative Therapy Before Surgery, & Correlation With Response
NCT04601727 ·Status: COMPLETED
-
Study of Fruquintinib Combined With Tegafur Gimeracil Oteracil in Patients With Metastatic Colorectal Cancer
NCT06255379 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Investigation of the Value of ctDNA in Diagnosis, Treatment, and Surveillance of Surgically Resectable Colorectal Cancer
NCT03038217 ·Status: UNKNOWN ·Phase: PHASE3
-
The Application Value of Spectral CT in the Accurate Staging of Colorectal Cancer
NCT06977373 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Application of Circulating Tumor DNA Test in the Diagnosis and Treatment of Patients With Advanced Rectal Cancer
NCT03615170 ·Status: UNKNOWN
-
Metabolomics to Predict Treatment Response and Toxicities in Rectal Cancer
NCT06831669 ·Status: RECRUITING
-
Distinct Metastatic Phenotypes Between Early-onset and Late-onset Colorectal Cancer
NCT06040021 ·Status: COMPLETED
-
Second Primary Cancer and Early-onset Colorectal Cancer
NCT06423924 ·Status: NOT_YET_RECRUITING
-
Detection and Enumeration of Circulating Tumor Cells in Rectal Cancer
NCT01671891 ·Status: UNKNOWN
-
Study of Biomarkers in Tissue Samples From Patients With Metastatic Colon Cancer
NCT01012804 ·Status: WITHDRAWN
-
Molecular Study and Precision Medicine for Colorectal Cancer
NCT05883683 ·Status: NOT_YET_RECRUITING
-
Multicenter Cohort Prospective Study on Multidisciplinary Treatment of Rectal Cancer
NCT01651026 ·Status: UNKNOWN
-
Predictive Factors for Outcomes of Fruquintinib Plus Immunotherapy in Colorectal Cancer
NCT05635149 ·Status: UNKNOWN
-
Genotype-directed Neoadjuvant Chemoradiation for Rectal Carcinoma
NCT00682786 ·Status: COMPLETED ·Phase: PHASE2
-
Genomic Signatures for Patients With Initially Unresectable Colorectal Liver Metastases
NCT06477718 ·Status: COMPLETED
-
Rectal Study: Value of Repeated FDG-PET-CT Scans in Rectal Cancer
NCT00576563 ·Status: COMPLETED ·Phase: NA
-
The Prediction Model of Avastin Plus Chemotherapy in Unresectable Ras Mutant CRLM Patients
NCT04525313 ·Status: UNKNOWN
-
PET-CT and Circulating Tumor Cells in Colorectal Cancer
NCT01163305 ·Status: COMPLETED
-
Observational Study on the Patients With Rectal Cancer
NCT02312284 ·Status: COMPLETED
-
The Molecular Mechanism of RAS Wild-type mCRC Resistance to Anti-EGFR-antibody
NCT04466267 ·Status: COMPLETED
-
A Longitudinal Study of Cancer-related Fatigue Among Colorectal Cancer Patients During Adjuvant Chemotherapy
NCT03013972 ·Status: UNKNOWN
-
Real-World Effectiveness of Regorafenib in the Treatment of Patients With Metastatic Colorectal Cancer
NCT05023720 ·Status: UNKNOWN
-
Circulating Tumor DNA Methylation Guiding Postoperative Adjuvant Chemotherapy in Stage III Colorectal Cancer
NCT06167967 ·Status: RECRUITING ·Phase: NA
-
Clinicopathological Characteristics of Colon Cancer in Young Age
NCT05365412 ·Status: RECRUITING